Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 25;86(11):6898-6899.
doi: 10.1097/MS9.0000000000002599. eCollection 2024 Nov.

Cytoreductive surgery for oligometastatic prostate cancer: a promising strategy - correspondence

Jia Luo  1 , Qian Yang  1 , Wen Ma  1 , Hua Fan  1
Affiliations

Cytoreductive surgery for oligometastatic prostate cancer: a promising strategy - correspondence

Jia Luo et al. Ann Med Surg (Lond). .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.

Similar articles

See all similar articles

References

    1. Rajwa P, Robesti D, Chaloupka M, et al. . Outcomes of cytoreductive radical prostatectomy for oligometastatic prostate cancer on prostate-specific membrane antigen positron emission tomography: results of a multicenter European study. Eur Urol Oncol 2023;S2588-9311:00197–00199. - PubMed
    1. Cheng B, He H, Chen B, et al. . Assessment of treatment outcomes: cytoreductive surgery compared to radiotherapy in oligometastatic prostate cancer - an in-depth quantitative evaluation and retrospective cohort analysis. Int J Surg 2024;110:3190–3202. - PMC - PubMed
    1. Cheng B, Li B, Fu J, et al. . Evaluating the effectiveness of cytoreductive surgery in oligometastatic prostate cancer: insights from quantitative analysis and retrospective cohort studies. Int J Surg 2024. [Online ahead of print]. [PMID: 39007913]. - PMC - PubMed
    1. Engel J, Bastian PJ, Baur H, et al. . Survival benefit of radical prostatectomy in lymph node-positive patients with prostate cancer. Eur Urol 2010;57:754–761. - PubMed
    1. Lan T, Chen Y, Su Q, et al. . Oncological outcome of cytoreductive radical prostatectomy in prostate cancer patients with bone oligometastases. Urology 2019;131:166–175. - PubMed

LinkOut - more resources